Literature DB >> 20628317

Successful treatment of late, recurrent wilms tumor with high-dose chemotherapy and autologous stem cell rescue in third complete response.

Evangeline Brown1, Andre Hebra, Joseph Jenrette, Michelle Hudspeth.   

Abstract

SUMMARY: Wilms tumor relapses are infrequent, occurring in approximately 15% of favorable histology patients. Very few cases of late recurrent relapse exist in the literature. Long-term survival after autologous stem cell rescue ranges from 40% to 73%, but there are very few reports of patients transplanted in their third complete response. We report a late recurrent relapse of Wilms tumor successfully treated with high-dose chemotherapy and autologous stem cell rescue in his third complete response who remains disease free 15 months posttransplant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628317     DOI: 10.1097/MPH.0b013e3181e5e25b

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Wilms' Tumor with long-delayed recurrence: 25 years after initial treatment.

Authors:  So-Young Lee; Kyu-Rae Kim; Jung-Yeol Park; Jae Y Ro
Journal:  Korean J Urol       Date:  2012-04-18

2.  Relapsed Wilms' tumor with multiple brain metastasis.

Authors:  Akın Akakın; Baran Yılmaz; Murat Şakir Ekşi; Özlem Yapıcıer; Türker Kılıç
Journal:  Korean J Pediatr       Date:  2016-11-30

3.  Variant profiles of genes mapping to chromosome 16q loss in Wilms tumors reveals link to cilia-related genes and pathways.

Authors:  Eiko Kitamura; John K Cowell; Chang-Sheng Chang; Lesleyann Hawthorn
Journal:  Genes Cancer       Date:  2020-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.